Redwood Investment Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Redwood Investment Management's DGX Position: Q2 2023 in Review
Redwood Investment Management sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 10,994 shares — an estimated $1.55M sold.
Redwood Investment Management first reported a position in DGX in Q2 2020 and held it in 9 quarters. The position peaked at $5.94M in Q4 2021. 820 funds tracked by Wall St. Rank hold DGX as of Q2 2023.
- Redwood Investment Management reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
- Redwood Investment Management sold 10,994 Quest Diagnostics shares in Q2 2023, an estimated $1.55M.
- Redwood Investment Management first reported a position in Quest Diagnostics in Q2 2020 and held it in 9 quarters.
- Redwood Investment Management's Quest Diagnostics position peaked at $5.94M in Q4 2021.
- 820 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.
Based on Redwood Investment Management's 13F filing for Q2 2023, filed 15 Aug 2023.